SCP Vitalife Partners logo

SCP Vitalife Partners

North America, Pennsylvania, United States, Wayne

Description

SCP Vitalife Partners is a venture capital firm focused on life science investments in Israel and the U.S.

Investor Profile

SCP Vitalife Partners has made 15 investments, with 0 in the past 12 months and 20% as lead.

Stage Focus

  • Series Unknown (33%)
  • Series D (27%)
  • Series C (20%)
  • Series A (7%)
  • Seed (7%)
  • Series F (7%)

Country Focus

  • Israel (53%)
  • United States (47%)

Industry Focus

  • Health Care
  • Medical Device
  • Biotechnology
  • Medical
  • Pharmaceutical
  • Manufacturing
  • Robotics
  • Wellness
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does SCP Vitalife Partners frequently co-invest with?

Abingworth
Europe, England, United Kingdom, London
Co-Investments: 1
EV
North America, Massachusetts, United States, Waltham
Co-Investments: 1
DeNovo Ventures
North America, California, United States, Saratoga
Co-Investments: 1
Israel Healthcare Ventures
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 2
Easterly Capital
North America, Massachusetts, United States, Beverly
Co-Investments: 2
Medica Venture Partners
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 2
Borealis Ventures
North America, New Hampshire, United States, Hanover
Co-Investments: 1
Cardinal Partners
North America, New Jersey, United States, Princeton
Co-Investments: 2
Aperture Venture Partners
North America, New York, United States, New York
Co-Investments: 2
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 2

Which angels does SCP Vitalife Partners often collaborate with?

M. Carl Johnson
North America, California, United States, San Francisco
Shared Deals: 1
Dov Moran
Asia, HaMerkaz, Israel, Kfar Saba
Shared Deals: 1

What are some of recent deals done by SCP Vitalife Partners?

Regentis Biomaterials

Or Akiva, Hefa, Israel

Regentis Biomaterials develops and commercializes proprietary hydrogels for tissue regeneration.

BiotechnologyHealth CareMedical Device
Series DFeb 7, 2016
Amount Raised: $15,000,000
Ivenix

Amesbury, Massachusetts, United States

Ivenix is a medical technology company that has developed an infusion pump.

Health CareMedicalMedical Device
Series UnknownSep 1, 2015
Amount Raised: $42,000,000
Sensible Medical Innovations

Netanya, HaMerkaz, Israel

Sensible Medical Innovation offers sensing and monitoring for the management and treatment of several chronic medical conditions.

BiotechnologyHealth CareMedical Device
Series UnknownNov 11, 2013
Amount Raised: $20,000,000
Rewalk Robotics

Marlborough, Massachusetts, United States

Rewalk Robotics is a medical device company that develops wearable robotic exoskeleton for individuals with lower limb disabilities.

ManufacturingMedicalMedical DeviceRoboticsWellness
Series DJun 17, 2013
Amount Raised: $1,200,000
Avedro

Waltham, Massachusetts, United States

Avedro is a medical device and pharmaceutical company advancing the science and technology of corneal cross-linking.

Health CareMedical DevicePharmaceutical
Series DMar 5, 2013
Amount Raised: $43,000,000
Regentis Biomaterials

Or Akiva, Hefa, Israel

Regentis Biomaterials develops and commercializes proprietary hydrogels for tissue regeneration.

BiotechnologyHealth CareMedical Device
Series CMay 14, 2012
Amount Raised: $10,000,000
Avedro

Waltham, Massachusetts, United States

Avedro is a medical device and pharmaceutical company advancing the science and technology of corneal cross-linking.

Health CareMedical DevicePharmaceutical
Series UnknownFeb 21, 2012
Amount Raised: $500,000
Fluidnet

Amesbury, Massachusetts, United States

Fluidnet develops technologies for infusion systems that deliver medication and fluids to patients.

Health CareMedicalMedical Device
Series CAug 16, 2011
Amount Raised: $25,000,000
Avedro

Waltham, Massachusetts, United States

Avedro is a medical device and pharmaceutical company advancing the science and technology of corneal cross-linking.

Health CareMedical DevicePharmaceutical
Series CJul 7, 2011
Amount Raised: $25,000,000
NovoGI

Netanya, HaMerkaz, Israel

NovoGI develops medical devices and services that focus on gastrointestinal disease management.

BiotechnologyHealth CareHealth DiagnosticsMedical Device
Series FAug 11, 2009
Amount Raised: $18,500,000